Otto Kauko
- Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling (2015)
- Scientific Reports
- Protein phosphatase 2A activity is a major determinant of therapy response in cancer cells (2015)
- Cancer Research
- Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells (2013)
- Cancer Research
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes (2012)
- Oncogene



